Skip to main content

News

Orsif
meeting update
10/28/2024
HMP Global, in partnership with Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), will host the first-of-its-kind Global Symposium on Interventional Radiation Protection (SIRP), to be held September 26-27, 2025.
HMP Global, in partnership with Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), will host the first-of-its-kind Global Symposium on Interventional Radiation Protection (SIRP), to be held September 26-27, 2025.
HMP Global, in partnership with...
10/28/2024
EP Lab Digest
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the pre-defined performance goal (see figure 1).
Mechanical Circulatory Support
10/28/2024
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the...
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the...
The pivotal investigational...
10/28/2024
Cath Lab Digest
Press Release
10/25/2024
Medtronic Press Release  GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the...
Medtronic Press Release  GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the...
Medtronic Press...
10/25/2024
EP Lab Digest
Press Release
10/24/2024
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Adagio Medical Holdings, Inc.,...
10/24/2024
EP Lab Digest
Press Release
10/24/2024
The reprocessing company seeks to further improve its already impressive impact on greenhouse gas emissions in healthcare
The reprocessing company seeks to further improve its already impressive impact on greenhouse gas emissions in healthcare
The reprocessing company seeks...
10/24/2024
EP Lab Digest
Press Release
10/22/2024
Catheter Precision Press Release  FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac...
Catheter Precision Press Release  FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac...
Catheter Precision Press...
10/22/2024
EP Lab Digest
Press Release
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for...
Philips portfolio of...
10/21/2024
EP Lab Digest
Press Release
10/18/2024
The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm Advocates, a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit...
The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm Advocates, a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit...
The Heart Rhythm Society (HRS)...
10/18/2024
EP Lab Digest
Press Release
10/18/2024
Tenaya Therapeutics Press Release SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies...
Tenaya Therapeutics Press Release SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies...
Tenaya Therapeutics Press...
10/18/2024
EP Lab Digest
Press Release
10/18/2024
Boston Scientific Press Release  MARLBOROUGH, Mass., Oct. 18, 2024 -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the navigation-enabled...
Boston Scientific Press Release  MARLBOROUGH, Mass., Oct. 18, 2024 -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the navigation-enabled...
Boston Scientific Press...
10/18/2024
EP Lab Digest